- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01811316
A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis
Studieoversikt
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Massachusetts
-
Cambridge, Massachusetts, Forente stater, 02142
- The Forsyth Institute
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Willing and able to read, understand and sign an Informed Consent form.
- Good general health as evidenced by the medical history.
- Between 18 and 65 years of age.
- Male or female.
- Minimum of 20 teeth, excluding crowns and third molar teeth.
- Mean whole mouth Modified Gingival Index of greater-than or equal to 2.0 at baseline.
- Willing to abstain from all oral hygiene procedures for 12-18 hours prior to clinical visits.
- Willing to abstain from eating and drinking in the morning of visits, only drinking water is allowed.
- Willing to abstain from interdental cleaning, chewing gums, oral whitening, mouth rinse and tobacco products for the study duration.
- Able to understand and follow study directions.
- No known history of allergy to dairy products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.
Exclusion Criteria
- Presence of orthodontic appliances.
- Intra-oral soft tissue lesions due to pathology or trauma
- Patients with aggressive periodontitis, acute necrotizing ulcerative gingivitis, or gross decay at discretion of PI.
- More than two sites with pocket depth >5mm and concomitant attachment loss of >2mm.
- Pregnant or lactating females or females of child bearing potential not using acceptable methods of birth control (hormonal, barriers or abstinence).
- Use of antibiotics within 3 months of enrollment
- History of drug use that is associated with gum overgrowth (i.e., Dilantin, nifedipine, etc)
- Chronic use of medication such as steroids, NSAIDs (more than 2-3 days/week), anti-coagulant medications, immunosuppressant medications or any other medications that in the opinion of the Investigator would interfere with the evaluation or confound interpretation of the study results. Use of low dose of acetylsalicylic acid (81 mg) is permitted.
- Unwilling to sign a confidentiality statement and/or return the test products.
- Medical condition which requires pre-medication prior to dental visits/procedures.
- Immune compromised individuals (HIV, AIDS, immunosuppressive drug therapy).
- Current use of probiotics or probiotic containing food (i.e., yogurt)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Probiotics Lozenge (twice a day)
Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.
|
|
Aktiv komparator: Probiotics Lozenge (once a day)
Subjects take their lozenge once a day, one lozenge at night after brushing.
|
|
Placebo komparator: Placebo Lozenge (once a day)
Subjects take their lozenge once a day, one lozenge at night after brushing.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change From Baseline in Modified Gingival Index (MGI)
Tidsramme: 4, 12 and 24 weeks
|
Modified Gingival Index (MGI) (Lobene, Weatherford et al. 1986) was measured on six gingival areas of all scorable teeth, using a scale of 0-4 as follows: Scores Criteria 0 Normal (absence of inflammation)
Whole mouth MGI scores were calculated by summing all scores and dividing by the number of examined scorable sites. |
4, 12 and 24 weeks
|
Change From Baseline in Bleeding on Probing (BOP)
Tidsramme: 4, 12 and 24 weeks
|
Bleeding on probing was assessed 30 seconds after probing.
A dichotomous scoring system was used at six sites per tooth using one (1) and zero (0) for presence or absence, respectively.
BOP (%) is a percentage of sites BOP.
|
4, 12 and 24 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change From Baseline in Plaque Index (PI)
Tidsramme: 4, 12 and 24 weeks
|
Plaque Index of Turesky Modification of Quigley-Hein (Turesky, Gilmore et al. 1970) (PI) was scored on all natural teeth (except third molars) after disclosing with erythrosine solution. Scores Criteria: 0 No plaque
|
4, 12 and 24 weeks
|
Change From Baseline in Probing Depth (PD)
Tidsramme: 4, 12 and 24 weeks
|
Periodontal pocket depth (PD) was determined with a periodontal probe at six sites per tooth rounded to the next lower whole mm.
|
4, 12 and 24 weeks
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change From Baseline in Inflammatory Markers in Gingival Crevicular
Tidsramme: 15 days, 4, 12 and 24 weeks
|
Gingival Crevicular Fluid (GCF) samples will be analyzed for inflammatory cytokines/chemokines and matrix metalloproteases using multiplexing ELISA.
|
15 days, 4, 12 and 24 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Hatice Hasturk, DDS, PhD, The Forsyth Institute
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CLP-2013-1-23
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Probiotics
-
Mednax Center for Research, Education, Quality...Phoenix Children's Hospital; Banner University Medical CenterFullførtTotal parenteral ernæring | Nekrotiserende enterokolitt hos nyfødteForente stater
-
Connecticut Children's Medical CenterRekruttering
-
Maneuver MarketingCitruslabsAktiv, ikke rekrutterende
-
McMaster UniversityHar ikke rekruttert ennåKvinners helse | HjerneplastisitetCanada
-
University of North FloridaCelebrate Nutritional SupplementsRekruttering
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Technology Evaluation in... og andre samarbeidspartnereFullførtAntibiotika-assosiert diaré | Ventilator Associated Pneumonia (VAP) | Andre infeksjoner | C-Difficile | Varighet av mekanisk ventilasjon | Lengde på intensivavdelingen | Lengde på sykehusopphold | ICU og sykehusdødelighetForente stater, Canada
-
Medstar Health Research InstituteRekruttering
-
Columbia UniversityRekrutteringMultippel sklerose | Sunn ernæringForente stater
-
McMaster UniversityFullførtInfeksjoner | Diaré | Ventilator Associated Pneumonia | Antibiotika-assosiert diaré | C-DifficileCanada, Forente stater, Saudi-Arabia